• Experts debate efficacy of point-of-care A1C for diabetes diagnosis in joint ADA/AACC session

    Experts debate efficacy of point-of-care A1C for diabetes diagnosis in joint ADA/AACC session

    A1C is routinely used to monitor glycemic control for patients with diabetes. At the Scientific Sessions, Jay H. Shubrook, DO, FACOFP, FAAFP, BC-ADM, and David B. Sacks, MB ChB, FACP, FRCPath, debated whether point-of-care A1C should be part of the diagnostic toolkit for diabetes.

  • Researchers using GWAS data to explore genetic risk factors of diabetes

    Researchers using GWAS data to explore genetic risk factors of diabetes

    Marcela Brissova, PhD, Struan F.A. Grant, PhD, Maggie Ng, PhD, and Melina Claussnitzer, PhD, discussed how molecular and genetic studies are providing new insight into the influence of genetics in the development and progression of diabetes.

  • Kidney Precision Medicine Project and novel technologies provide new insight into DKD

    Kidney Precision Medicine Project and novel technologies provide new insight into DKD

    “The KPMP is all about using the kidney biopsy, which is an old tool, to understand kidney disease in a new way by almost turbocharging the information that we get,” said Jonathan Himmelfarb, MD.

  • Investigators describe single-cell multiomic studies of metabolic tissue function

    Investigators describe single-cell multiomic studies of metabolic tissue function

    New research uses single-cell technologies to explore the roles of adipocytes, macrophages, beta cells, and fibroblast growth factor-1 in metabolic tissue function. Qiong (Annabel) Wang, PhD, Christopher K. Glass, MD, PhD, Heiko Lickert, PhD, and Michael W. Schwartz, MD, reviewed this work at the Scientific Sessions.

  • Emerging science refines understanding of how triglycerides impact CVD risk

    Emerging science refines understanding of how triglycerides impact CVD risk

    Brian A. Ference, MD, MPhil, MSc, FACC, FESC, Lisa R. Tannock, MD, Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS, and Stephen G. Young, MD, discussed new insights into the role of triglycerides in cardiovascular disease at the Scientific Sessions.

  • Early-career investigators review new NIDDK-supported research

    Early-career investigators review new NIDDK-supported research

    A symposium sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases showcased current research by six young scientists—Emily K. Sims, MD, Emilyn U. Alejandro, PhD, Rafael Arrojo e Drigo, PhD, Camille E. Powe, MD, Rochelle N. Naylor, MD, and Joshua J. Joseph, MD, MPH, FAHA—aimed at developing a more stratified medical approach…

  • Open-source coding allows patients to build their own closed-loop systems

    Open-source coding allows patients to build their own closed-loop systems

    Patients have rallied behind the development of do-it-yourself automated insulin delivery systems to manage their diabetes. Natalie J. Bellini, MSN, FNP-BC, Dana Lewis, BA, Anna Norton, MS, and David M. Maahs, MD, PhD, discussed potential ramifications for patients, clinicians, researchers, and even manufacturers of commercial closed-loop devices.

  • Tackling diabetes requires taking on health inequities, panelists assert

    Tackling diabetes requires taking on health inequities, panelists assert

    “Equity is our goal,” said Tiffany L. Gary-Webb, PhD, MHS. “But the reality is right now we’re not anywhere near that. The reality is that some people have much more than they need and there are other people who are digging themselves out of a hole.”

  • Investigators review latest research exploring interorgan metabolic crosstalk

    Investigators review latest research exploring interorgan metabolic crosstalk

    Jonathan Z. Long, PhD, Yu-Hua Tseng, PhD, Kristin I. Stanford, PhD, and Anthony W. Ferrante, MD, PhD, discussed emerging understanding of how organ systems communicate to regulate and maintain energy homeostasis.

  • Investigators examine latest research on the role of beta cells in type 1 diabetes

    Investigators examine latest research on the role of beta cells in type 1 diabetes

    Recent and emerging research sheds new light on the role of beta cells in the development and progression of type 1 diabetes. Carmella Evans-Molina, MD, PhD, explained the association between beta cell function and immune therapy efficacy.

0